Sarah Scott is a Director at Pfizer, where they currently lead Launch Operations for Multiple Myeloma, a role they have held since 2021. Previously, they served as Director of Oncology Commercial Development and Director of Payer Insights and Access at Pfizer, focusing on oncology and inflammation biosimilars. Sarah began their career as an Analyst at IMS before progressing to Consultant roles at both IMS Consulting and Double Helix Consulting. They hold a PhD in Stem Cell Research from the University of Cambridge and a degree in Biochemistry from Cardiff University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices